Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: A study on 574 tissue specimens

Journal of Medical Virology

Volumn 84, Issue 8, 2012, Pages 1233-1241

  Komloš, Kristina Fujs ^a   Kocjan, Boštjan J ^a   Košorok, Pavle ^b   Luzar, Boštjan ^a   Meglič, Leon ^b   Potočnik, Marko ^b   Hočevar Boltežar, Irena ^b   Gale, Nina ^a   Seme, Katja ^a   Poljak, Mario ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Anogenital warts; HPV; Human papillomavirus; Laryngeal papillomas; Slovenia

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONDYLOMA ACUMINATUM; ETHNICITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; LARYNX PAPILLOMATOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PREVALENCE; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANAL CANAL; CONDYLOMATA ACUMINATA; DNA, VIRAL; FEMALE; GENITALIA; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 6; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PAPILLOMA; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SEX FACTORS; SLOVENIA; YOUNG ADULT;

EID: 84862654119     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23318     Document Type: Article

References (70)

1. Aubin F, Prétet JL, Jacquard AC, Saunier M, Carcopino X, Jaroud F, Pradat P, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D, EDiTH Study Group. 2008. Human papillomavirus genotype distribution in external acuminata condylomata: A Large French National Study (EDiTH IV). Clin Infect Dis 47: 610-615.
2. Balažic J, Mašera A, Poljak M. 1997. Sudden death caused by laryngeal papillomatosis. Acta Otolaryngol (Stockh) Suppl 527: 111-113.
3. Ball SL, Winder DM, Vaughan K, Hanna N, Levy J, Sterling JC, Stanley MA, Goon PK. 2011. Analyses of human papillomavirus genotypes and viral loads in anogenital warts. J Med Virol 83: 1345-1350.
4. Beckmann AM, Sherman KJ, Myerson D, Daling JR, McDougall JK, Galloway DA. 1991. Comparative virologic studies of condylomata acuminata reveal a lack of dual infections with human papillomaviruses. J Infect Dis 163: 393-396.
5. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. 2010. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401: 70-79.
6. Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH. 1999. Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 37: 3316-3322.
7. Cardoso JC, Calonje E. 2011. Cutaneous manifestations of human papillomaviruses: A review. Acta Dermatovenerol Alp Panonica Adriat 20: 145-154.
8. Chan PK, Luk AC, Luk TN, Lee KF, Cheung JL, Ho KM, Lo KK. 2009. Distribution of human papillomavirus types in anogenital warts of men. J Clin Virol 44: 111-114.
9. Chrisofos M, Skolarikos A, Lazaris A, Bogris S, Deliveliotis Ch. 2004. HPV 16/18-associated condyloma acuminatum of the urinary bladder: First international report and review of literature. Int J STD AIDS 15: 836-838.
10. Cook JR, Hill DA, Humphrey PA, Pfeifer JD, El-Mofty SK. 2000. Squamous cell carcinoma arising in recurrent respiratory papillomatosis with pulmonary involvement: Emerging common pattern of clinical features and human papillomavirus serotype association. Mod Pathol 13: 914-918.
11. Coutlée F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, Voyer H, Franco E. 2002. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40: 902-907.
12. Coutlée F, Rouleau D, Petignat P, Ghattas G, Kornegay JR, Schlag P, Boyle S, Hankins C, Vézina S, Coté P, Macleod J, Voyer H, Forest P, Walmsley S, Canadian Women's study HIV Group, Franco E. 2006. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Microbiol 44: 1998-2006.
13. D'Ambrogio A, Yerly S, Sahli R, Bouzourene H, Demartines N, Cotton M, Givel JC. 2009. Human papilloma virus type and recurrence rate after surgical clearance of anal condylomata acuminata. Sex Transm Dis 36: 536-540.
14. Dianzani C, Calvieri S, Pierangeli A, Degener AM. 2004. Identification of human papilloma viruses in male dysplastic genital lesions. New Microbiol 27: 65-69.
15. Donne AJ, Hampson L, Homer JJ, Hampson IN. 2010. The role of HPV type in Recurrent Respiratory Papillomatosis. Int J Pediatr Otorhinolaryngol 74: 7-14.
16. Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK. 2011. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: Analysis of national sentinel surveillance data. Lancet Infect Dis 11: 39-44.
17. Draganov P, Todorov S, Todorov I, Karchev T, Kalvatchev Z. 2006. Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR Green real-time PCR. Int J Pediatr Otorhinolaryngol 70: 469-473.
18. Evans MF, Adamson CS, Simmons-Arnold L, Cooper K. 2005. Touchdown General Primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus. BMC Clin Pathol 5: 10.
19. Ferluga D, Luzar B, Vodovnik A, Poljak M, Cör A, Gale N, Kambic V. 1997. Langerhans cells in human papillomaviruses types 6/11 associated laryngeal papillomas. Acta Otolaryngol Suppl 527: 87-91.
20. Gale N. 2005. Papilloma/papillomatosis. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. Pathology and genetics of head and neck tumours. Lyon: IARC Press. pp 144-145.
21. Gale N, Zidar N. 2006. Benign and potentially malignant lesions of the squamous epithelium and squamous cell carcinoma. In: Cardesa A, Slootweg PJ, editors. Pathology of the head and neck. Heidelberg: Springer. pp 1-38.
22. Gale N, Poljak M, Kambič V, Ferluga D, Fischinger J. 1994. Laryngeal papillomatosis: Molecular, histopathological, and clinical evaluation. Virchows Arch 425: 291-295.
23. Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, Boslego J, Sattler C, Barr E, Koutsky LA. 2007. Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 356: 1928-1943.
24. Garland SM, Steben M, Sings HL, James M, Lu S, Railkar R, Barr E, Haupt RM, Joura EA. 2009. Natural history of genital warts: Analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 199: 805-814.
25. Garnock-Jones KP, Giuliano AR. 2011. Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine: For the prevention of genital warts in males. Drugs 71: 591-602.
26. Gerein V, Rastorguev E, Gerein J, Jecker P, Pfister H. 2005. Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year follow-up. Ann Otol Rhinol Laryngol 114: 463-471.
27. Gissmann L, Zur Hausen H. 1980. Partial characterization of viral DNA from human genital warts (Condylomata acuminata). Int J Cancer 25: 605-609.
28. Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjose S, Kjaer SK, Muñoz N, Schiffman M, Bosch FX. 2008. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 26: 17-28.
29. Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Jr., Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, Chang YH, Ferris D, Rouleau D, Bryan J, Marshall JB, Vuocolo S, Barr E, Radley D, Haupt RM, Guris D. 2011. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 364: 401-411.
30. Greer CE, Wheeler CM, Ladner MB, Beutner K, Coyne MY, Liang H, Langenberg A, Yen TS, Ralston R. 1995. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol 33: 2058-2063.
31. Hartley C, Hamilton J, Birzgalis AR, Farrington WT. 1994. Recurrent respiratory papillomatosis-The Manchester experience, 1974-1992. J Laryngol Otol 108: 226-229.
32. Heinzel PA, Chan SY, Ho L, O'Connor M, Balaram P, Campo MS, Fujinaga K, Kiviat N, Kuypers J, Pfister H, Steinberg BM, Tay SK, Villa LL, Bernard HU. 1995. Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol 33: 1746-1754.
33. Jančar N, Kocjan BJ, Poljak M, Lunar MM, Bokal EV. 2009. Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia. Eur J Obstet Gynecol Reprod Biol 145: 184-188.
34. Kambič V, Gale N. editors. 1995. Epithelial hyperplastic lesions of the larynx. Amsterdam: Elsevier. 265 p.
35. Kjaer SK, Tran TN, Sparen P, Tryggvadottir L, Munk C, Dasbach E, Liaw KL, Nygård J, Nygård M. 2007. The burden of genital warts: A study of nearly 70, 000 women from the general female population in the 4 Nordic countries. J Infect Dis 196: 1447-1454.
36. Klavs I, Grgič-Vitek M. 2008. The burden of genital warts in Slovenia: Results from a national probability sample survey. Euro Surveill 13: 1-4.
37. Kliewer EV, Demers AA, Elliott L, Lotocki R, Butler JR, Brisson M. 2009. Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in Canada. Sex Transm Dis 36: 380-386.
38. Kocjan BJ, Poljak M, Seme K, Potocnik M, Fujs K, Babic DZ. 2005. Distribution of human papillomavirus genotypes in plucked eyebrow hairs from Slovenian males with genital warts. Infect Genet Evol 5: 255-259.
39. Kocjan BJ, Seme K, Poljak M. 2008. Detection and differentiation of human papillomavirus genotypes HPV-6 and HPV-11 by FRET-based real-time PCR. J Virol Methods 153: 245-249.
40. Kocjan BJ, Jelen MM, Maver PJ, Seme K, Poljak M. 2011. Pre-vaccination genomic diversity of human papillomavirus genotype 6 (HPV-6): A comparative analysis of 21 full-length genome sequences. Infect Genet Evol 11: 1805-1810.
41. Lacey CJ, Lowndes CM, Shah KV. 2006. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 24: 35-41.
42. Lack EE, Jenson AB, Smith HG, Healy GB, Pass F, Vawter GF. 1980. Immunoperoxidase localization of human papillomavirus in laryngeal papillomas. Intervirology 14: 148-154.
43. Larson DA, Derkay CS. 2010. Epidemiology of recurrent respiratory papillomatosis. APMIS 118: 450-454.
44. Lee LA, Cheng AJ, Fang TJ, Huang CG, Liao CT, Chang JT, Li HY. 2008. High incidence of malignant transformation of laryngeal papilloma in Taiwan. Laryngoscope 118: 50-55.
45. Lin KY, Westra WH, Kashima HK, Mounts P, Wu TC. 1997. Coinfection of HPV-11 and HPV-16 in a case of laryngeal squamous papillomas with severe dysplasia. Laryngoscope 107: 942-947.
46. Lin HW, Richmon JD, Emerick KS, de Venecia RK, Zeitels SM, Faquin WC, Lin DT. 2010. Malignant transformation of a highly aggressive human papillomavirus type 11-associated recurrent respiratory papillomatosis. Am J Otolaryngol 31: 291-296.
47. Luzar B, Gale N, Kambic V, Poljak M, Zidar N, Vodovnik A. 1997. Human papillomavirus infection and expression of p53 and c-erbB-2 protein in laryngeal papillomas. Acta Otolaryngol Suppl 527: 120-124.
48. Major T, Szarka K, Sziklai I, Gergely L, Czeglédy J. 2005. The characteristics of human papillomavirus DNA in head and neck cancers and papillomas. J Clin Pathol 58: 51-55.
49. Maloney EM, Unger ER, Tucker RA, Swan D, Karem K, Todd NW, Reeves WC. 2006. Longitudinal measures of human papillomavirus 6 and 11 viral loads and antibody response in children with recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 132: 711-715.
50. Mammas IN, Sourvinos G, Vakonaki E, Giamarelou P, Michael C, Spandidos DA. 2010. Novel human papilloma virus (HPV) genotypes in children with recurrent respiratory papillomatosis. Eur J Pediatr 169: 1017-1021.
51. Maver PJ, Poljak M, Seme K, Kocjan BJ. 2010. Detection and typing of low-risk human papillomavirus genotypes HPV 6, HPV 11, HPV 42, HPV 43 and HPV 44 by polymerase chain reaction and restriction fragment length polymorphism. J Virol Methods 169: 215-218.
52. Menton JF, Cremin SM, Canier L, Horgan M, Fanning LJ. 2009. Molecular epidemiology of sexually transmitted human papillomavirus in a self referred group of women in Ireland. Virol J 6: 112.
53. Mounts P, Shah KV, Kashima H. 1982. Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx. Proc Natl Acad Sci USA 79: 5425-5429.
54. Nielson CM, Harris RB, Flores R, Abrahamsen M, Papenfuss MR, Dunne EF, Markowitz LE, Giuliano AR. 2009. Multiple-type human papillomavirus infection in male anogenital sites: Prevalence and associated factors. Cancer Epidemiol Biomarkers Prev 18: 1077-1083.
55. Poljak M, Kocjan BJ. 2010. Commercially available assays for multiplex detection of alpha human papillomaviruses. Exp Rev Anti Infect Ther 8: 1139-1162.
56. Poljak M, Gale N, Kambic V, Luzar B. 1997. p53 protein overexpression in laryngeal squamous cell papillomas. Anticancer Res 17: 2201-2205.
57. Poljak M, Seme K, Gale N. 1998. Detection of human papillomaviruses in tissue specimens. Adv Anatomic Pathol 5: 216-234.
58. Poljak M, Seme K, Gale N. 2000. Rapid extraction of DNA from archival clinical specimens: Our experiences. Pflug Arch Eur J Physiol 439: 42-44.
59. Potočnik M, Kocjan BJ, Seme K, Poljak M. 2007. Distribution of human papillomavirus (HPV) genotypes in genital warts from males in Slovenia. Acta Dermatovenerol Alp Panonica Adriat 16: 91-98.
60. Rabah R, Lancaster WD, Thomas R, Gregoire L. 2001. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol 4: 68-72.
61. Rady PL, Schnadig VJ, Weiss RL, Hughes TK, Tyring SK. 1998. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53. Laryngoscope 108: 735-740.
62. Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK. 2011. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 87: 544-547.
63. Reidy PM, Dedo HH, Rabah R, Field JB, Mathog RH, Gregoire L, Lancaster WD. 2004. Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer. Laryngoscope 114: 1906-1909.
64. Rimell FL, Shoemaker DL, Pou AM, Jordan JA, Post JC, Ehrlich GD. 1997. Pediatric respiratory papillomatosis: Prognostic role of viral typing and cofactors. Laryngoscope 107: 915-918.
65. Skerlev M, Grce M, Sirotkoviae-Skerlev M, Husnjak K, Lipozenčić J. 2002. Human papillomavirus male genital infections: Clinical variations and the significance of DNA typing. Clin Dermatol 20: 173-178.
66. Tachezy R, Smahelova J, Salakova M, Arbyn M, Rob L, Skapa P, Jirasek T, Hamsikova E. 2011. Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPV. PLoS ONE 6: e21913.
67. Velyvyte D, Laiskonis A, Uloza V, Gozdzicka-Jozefiak A. 2002. Prevalence of papillomavirus infection among patients with laryngeal papillomatosis and the effects of some risk factors on the persistence of papillomaviruses in the upper respiratory tract. Medicina 38: 499-504.
68. Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L. 2004. Recurrent respiratory papillomatosis: A longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 114: 1-23.
69. Wiley DJ, Douglas J, Beutner K, Cox T, Fife K, Moscicki AB, Fukumoto L. 2002. External genital warts: Diagnosis, treatment, and prevention. Clin Infect Dis 35: 210-224.
70. Zur Hausen H. 2002. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2: 342-350.